Sera Anti-P53 Antibody Provides New Information Which Explains the Link Between Diabetes and Cancer.
Rani SauriasariAndisyah Putri SekarNurul AisyahRezi Riadhi SyahdiEiji MatsuuraPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2020)
Our results showed that anti-p53 antibody almost not detected in healthy subjects, but 8.3-fold increase in the sera of T2DM patients and 24-fold increase in T2DM patients with cancer. Therefore, this biomarker provides new information which explains the link between diabetes and cancer.